Centene Corporation (CNC)
Automate Your Wheel Strategy on CNC
With Tiblio's Option Bot, you can configure your own wheel strategy including CNC - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol CNC
- Rev/Share 378.4188
- Book/Share 42.8696
- PB 0.9214
- Debt/Equity 0.8394
- CurrentRatio 1.0845
- ROIC -0.1505
- MktCap 19316624938.0
- FreeCF/Share 6.8331
- PFCF 5.7558
- PE -3.6487
- Debt/Assets 0.2142
- DivYield 0
- ROE -0.2061
- Rating C+
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 5
- P/B Score 4
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | CNC | Goldman | -- | Sell | -- | $33 | Oct. 14, 2025 |
| Downgrade | CNC | Cantor Fitzgerald | Overweight | Neutral | -- | $38 | July 28, 2025 |
| Downgrade | CNC | Wells Fargo | Overweight | Equal Weight | -- | $30 | July 23, 2025 |
| Downgrade | CNC | TD Cowen | Buy | Hold | -- | $33 | July 21, 2025 |
| Downgrade | CNC | BofA Securities | Neutral | Underperform | -- | $30 | July 16, 2025 |
| Downgrade | CNC | Morgan Stanley | Overweight | Equal Weight | -- | $33 | July 10, 2025 |
| Downgrade | CNC | UBS | Buy | Neutral | -- | $45 | July 2, 2025 |
| Downgrade | CNC | JP Morgan | Overweight | Neutral | -- | $48 | July 2, 2025 |
| Resumed | CNC | Morgan Stanley | -- | Overweight | -- | $70 | June 9, 2025 |
| Downgrade | CNC | Barclays | Overweight | Equal Weight | -- | $65 | June 2, 2025 |
News
Hit By Costs And Medicaid Cuts, Centene Reports $6.6 Billion Loss
Published: October 29, 2025 by: Forbes
Sentiment: Negative
Health insurer Centene reported a $6.6 billion third-quarter loss as the company struggles to control rising healthcare costs in the government-subsidized health plans it administers and sells.
Read More
Centene Swings to Loss on Writedown
Published: October 29, 2025 by: WSJ
Sentiment: Negative
Centene swung to a third-quarter loss as enrollees in Affordable Care Act plans sought out more costly medical care, the latest evidence of health insurers' struggles to regain their former profitability.
Read More
Centene Stock Spikes on Third-Quarter Earnings. Here's Why.
Published: October 29, 2025 by: Barrons
Sentiment: Positive
Centene's health benefits ratio increases to 92.7% in the quarter from 89.2% in the same period last year.
Read More
CENTENE CORPORATION REPORTS THIRD QUARTER 2025 RESULTS
Published: October 29, 2025 by: PRNewsWire
Sentiment: Neutral
-- GAAP Diluted Loss Per Share of $(13.50); Adjusted Diluted Earnings Per Share of $0.50 -- Adjusted diluted EPS of $0.50 in the third quarter of 2025, including a $0.10 benefit of a low adjusted effective tax rate in the quarter as compared to the expected full year adjusted effective tax rate of 20-21%. $6.7 billion non-cash goodwill impairment, resulting in a GAAP loss and corresponding reduction of retained earnings in the third quarter of 2025.
Read More
Can Centene's Q3 Earnings Escape Industry's Cost Headwinds?
Published: October 27, 2025 by: Zacks Investment Research
Sentiment: Neutral
CNC braces for Q3 results as revenue growth may be offset by rising medical costs and shrinking Medicaid memberships.
Read More
UnitedHealth Vs. Centene: Next Week's Q3 Earnings Should Trigger Gains For Both
Published: October 24, 2025 by: Seeking Alpha
Sentiment: Positive
UnitedHealth Group Incorporated and Centene Corporation remain heavily discounted after recent selloffs, but are poised for recovery ahead of Q3 earnings. Both UNH and CNC withdrew guidance in 2025 due to rising healthcare utilization and margin pressure, but recent signals suggest stabilization and improving outlooks. CMS's commitment to higher Medicare Advantage rates in 2026 and improving Medicaid margins supports a bullish stance on both stocks.
Read More
Centene: Strong Buy, For All The Wrong Reasons
Published: October 21, 2025 by: Seeking Alpha
Sentiment: Neutral
Centene moat shows cracks, yet valuation implies a full collapse. CNC's scale remains an asset, though it no longer guarantees stability. Efficiency gains have peaked, leaving limited room for.
Read More
WellCare of North Carolina Invests in More than 40 Local Nonprofits to Support Community Health Across the State
Published: October 08, 2025 by: PRNewsWire
Sentiment: Neutral
RALEIGH, N.C. , Oct. 8, 2025 /PRNewswire/ -- WellCare of North Carolina (WellCare), an NC Medicaid health plan and subsidiary of Centene Corporation (NYSE: CNC), is supporting health-related resources for communities across North Carolina through over $1.6M of investments in local nonprofit organizations.
Read More
Centene Sits at 13.25X P/E: Time to Load Up or Look Away for Now?
Published: September 26, 2025 by: Zacks Investment Research
Sentiment: Neutral
CNC's low 13.25X P/E may look attractive, but falling margins, heavy debt and shrinking memberships paint a tougher picture.
Read More
Meridian Health Plan of Illinois Rewards Providers with $15M for Improved Health Outcomes
Published: September 23, 2025 by: PRNewsWire
Sentiment: Neutral
Meridian and its providers are increasing access to high-quality care for over 340,000 Medicaid members statewide through value-based partnerships, resulting in a 21% reduction in emergency room visits. CHICAGO , Sept.
Read More
Carolina Complete Health and the Centene Foundation Award $1.3 Million Grant for Innovative Health Care Workforce Mental Health Program
Published: September 16, 2025 by: PRNewsWire
Sentiment: Neutral
Multi-year initiative aims to combat clinician burnout and improve mental health support across North Carolina's healthcare workforce DURHAM, N.C. , Sept. 16, 2025 /PRNewswire/ -- The North Carolina Clinician and Physician Retention and Well-being (NCCPRW) Consortium announced today a transformative $1.3 million grant from the Centene Foundation, the philanthropic arm of Centene Corporation (NYSE: CNC), and Carolina Complete Health, a provider-led Medicaid health plan created by Centene, the North Carolina Medical Society, and the North Carolina Community Health Center Association.
Read More
Why I'm Buying More UnitedHealth Than Centene
Published: September 12, 2025 by: Seeking Alpha
Sentiment: Positive
UnitedHealth Group stands out as the preferred pick over Centene due to scale, diversification, and higher profitability. UNH's integrated model and Optum platform provide more growth avenues and resilience compared to CNC's focus on government-sponsored programs. While CNC trades at a discount, UNH's stronger margins, return on equity, and diversified revenue streams justify its premium valuation.
Read More
Top Stock Movers Now: Centene, Micron Technology, Oracle, and More
Published: September 11, 2025 by: Investopedia
Sentiment: Positive
U.S. equities gained at midday, with the S&P 500 and Nasdaq adding to Wednesday's latest closing record highs, as new inflation and unemployment reports boosted confidence the Federal Reserve will cut interest rates next week. The Dow Jones Industrial Average was more than 1% higher.
Read More
Centene stock climbs on outlook, 'better than feared' Medicaid update
Published: September 11, 2025 by: Proactive Investors
Sentiment: Positive
Centene Corp (NYSE:CNC) shares gained 12% to $34.94 in late-morning trading Thursday after the health insurer's CEO Sarah London told the Deutsche Bank Healthcare conference the company's preliminary data for quality ratings for Medicare Advantage showed a slightly higher percentage of members in four-star plans. London also mentioned Centene's stronger-than-expected Medicaid results in July and August, which support better results in the second half of the year.
Read More
Centene Corporation (CNC) Presents At Deutsche Bank Healthcare Summit Transcript
Published: September 11, 2025 by: Seeking Alpha
Sentiment: Neutral
Centene Corporation (NYSE:CNC ) Deutsche Bank Healthcare Summit September 11, 2025 8:00 AM EDT Company Participants Sarah London - CEO & Director Andrew Asher - Chief Financial Officer Conference Call Participants George Hill - Deutsche Bank AG, Research Division Presentation George Hill MD & Equity Research Analyst Good morning, everybody. Welcome to day 2 of the DB Healthcare Summit.
Read More
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Centene Corporation of Class Action Lawsuit and Upcoming Deadlines - CNC
Published: September 08, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , Sept. 8, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Centene Corporation ("Centene" or the "Company")(NYSE: CNC).
Read More
Centene Corporation Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - CNC
Published: September 08, 2025 by: PRNewsWire
Sentiment: Neutral
LOS ANGELES , Sept. 8, 2025 /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of Centene Corporation ("Centene" or "the Company") (NYSE: CNC) for violations of the securities laws.
Read More
CNC Investors Have Opportunity to Lead Centene Corporation Securities Fraud Lawsuit with the Schall Law Firm
Published: September 08, 2025 by: PRNewsWire
Sentiment: Neutral
LOS ANGELES , Sept. 8, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Centene Corporation ("Centene" or "the Company") (NYSE: CNC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Read More
CNC Deadline: CNC Investors with Losses in Excess of $100K Have Opportunity to Lead Centene Corporation Securities Fraud Lawsuit
Published: September 05, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , Sept. 5, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Centene Corporation (NYSE: CNC) between December 12, 2024 and June 30, 2025, both dates inclusive (the "Class Period"), of the important September 8, 2025 lead plaintiff deadline.
Read More
CENTENE ALERT: Bragar Eagel & Squire, P.C. Urges Investors in Centene Corporation (CNC) to Inquire About Their Rights in Class Action Lawsuit Before the September 8th Deadline
Published: September 05, 2025 by: GlobeNewsWire
Sentiment: Neutral
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Centene Corporation (CNC) To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Centene between December 12, 2024 to June 30, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648.
Read More
Class Action Filed Against Centene Corporation (CNC) - September 8, 2025 Deadline to Join - Contact Levi & Korsinsky
Published: September 05, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , Sept. 5, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Centene Corporation ("Centene" or the "Company") (NYSE: CNC) of a class action securities lawsuit.
Read More
Deadline Alert: Centene Corporation (CNC) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
Published: September 04, 2025 by: GlobeNewsWire
Sentiment: Neutral
LOS ANGELES, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming September 8, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Centene Corporation (“Centene” or the “Company”) (NYSE: CNC) securities between December 12, 2024 to June 30, 2025, inclusive (the “Class Period”).
Read More
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Centene
Published: September 03, 2025 by: GlobeNewsWire
Sentiment: Neutral
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Centene To Contact Him Directly To Discuss Their Options
Read More
Centene Corporation Investors: Please contact the Portnoy Law Firm to recover your losses. September 8, 2025 Deadline to file Lead Plaintiff Motion
Published: September 02, 2025 by: GlobeNewsWire
Sentiment: Neutral
Investors can contact the law firm at no cost to learn more about recovering their losses
Read More
Class Action Filed Against Centene Corporation (CNC) – September 8, 2025 Deadline to Join – Contact Levi & Korsinsky
Published: September 02, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Centene Corporation ("Centene" or the "Company") (NYSE: CNC) of a class action securities lawsuit.
Read More
CNC Investors Have Opportunity to Join Centene Corporation Fraud Investigation with the Schall Law Firm
Published: September 02, 2025 by: PRNewsWire
Sentiment: Neutral
LOS ANGELES , Sept. 2, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Centene Corporation ("Centene" or "the Company") (NYSE: CNC) for violations of the securities laws.
Read More
Lead Plaintiff Deadline on September 8, 2025 for CNC Investors - Kessler Topaz Meltzer & Check, LLP Encourages Investors with Losses to Contact the Firm
Published: September 02, 2025 by: PRNewsWire
Sentiment: Neutral
RADNOR, Pa. , Sept. 2, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Centene Corporation ("Centene") (NYSE: CNC) on behalf of those who purchased or otherwise acquired Centene securities between December 12, 2024, and June 30, 2025, inclusive (the "Class Period").
Read More
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Centene Corporation of Class Action Lawsuit and Upcoming Deadlines - CNC
Published: September 02, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Centene Corporation (“Centene” or the “Company”)(NYSE: CNC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
Read More
CENTENE CORPORATION (NYSE: CNC) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Centene Corporation Investors of Upcoming Deadline
Published: September 02, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Centene Corporation (“Centene” or the “Company”) (NYSE: CNC) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.
Read More
CNC ALERT: Centene (CNC) Sued as Investors Allege Company Concealed Financial Risks – Hagens Berman
Published: September 02, 2025 by: GlobeNewsWire
Sentiment: Neutral
CNC Investors with Losses Encouraged to Contact the Firm Before Sept. 8th Deadline CNC Investors with Losses Encouraged to Contact the Firm Before Sept. 8th Deadline
Read More
About Centene Corporation (CNC)
- IPO Date 2001-12-13
- Website https://www.centene.com
- Industry Medical - Healthcare Plans
- CEO Sarah M. London
- Employees 60400